Bvg Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.50 M
as on 23-10-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.95 M
as on 23-10-2024
- Revenue -91.15%
(FY 2023)
- Profit -98.93%
(FY 2023)
- Ebitda -98.54%
(FY 2023)
- Net Worth 2.08%
(FY 2023)
- Total Assets 6.87%
(FY 2023)
About Bvg Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.95 M.
Hanmantrao Gaikwad, Ganesh Limaye, Vikas Nipane, and One other member serve as directors at the Company.
- CIN/LLPIN
U15490PN2014PLC151669
- Company No.
151669
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2014
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bvg Life Sciences Limited offer?
Bvg Life Sciences Limited offers a wide range of products and services, including Solar Products, Solar Insect Trap, Water Treatment & Purification Plant, Water Softening Systems, Plant Growth Promoters, Crop Yield Booster, Animal Feed Supplement, Cattle Feed Supplement, Fertilizers and Soil Additives, Organic Fertilizers and Manure.
Who are the key members and board of directors at Bvg Life Sciences?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hanmantrao Gaikwad | Director | 03-Jul-2014 | Current |
Ganesh Limaye | Director | 01-Mar-2019 | Current |
Vikas Nipane | Director | 02-Mar-2022 | Current |
Pawan Singh | Whole-Time Director | 28-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Bvg Life Sciences.
Bvg Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 91.15% decrease. The company also saw a substantial fall in profitability, with a 98.93% decrease in profit. The company's net worth moved up by a moderate rise of 2.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bvg Life Sciences?
In 2023, Bvg Life Sciences had a promoter holding of 74.20% and a public holding of 25.80%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Satara Mega Food Park Private LimitedActive 12 years 9 months
Hanmantrao Gaikwad and Vikas Nipane are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 31 Dec 2020 | ₹3.95 M | Open |
How Many Employees Work at Bvg Life Sciences?
Bvg Life Sciences has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bvg Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bvg Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.